Brownsville Moves to Level 2 On Threat Level Matrix

Translate to Spanish or other 102 languages!

Effective 7/5/22, the City of Brownsville has increased the threat level matrix to level two due to a rising number of COVID-19 cases. Image for illustration purposes
Effective 7/5/22, the City of Brownsville has increased the threat level matrix to level two due to a rising number of COVID-19 cases. Image for illustration purposes

Mega Doctor News

- Advertisement -

BROWNSVILLE, Texas – Effective 7/5/22, the City of Brownsville has increased the threat level matrix to level two due to a rising number of COVID-19 cases. During the past two weeks, virus transmission rates have increased, especially for unvaccinated individuals.

The number of positive COVID-19 cases has surpassed 1,000 cases, with two confirmed deaths this week. The public must stay vigilant and aware that this can take a toll on every member of the community, including the most vulnerable and healthcare staff. 

“We want to remind citizens that it is essential to continue to be vigilant and practice safe health practices. Please remember to wash your hands, use hand sanitizer, practice social distancing, and wear a mask,” said Dr. Rodriguez.

- Advertisement -

Currently, the vaccination rate for Cameron County is at 92.80% for individuals 65 years and older and 81.83% for people five years and older.  Getting the COVID-19 vaccine has been found to be the safest and most effective way to protect the immune system from COVID-19. Call the COVID-19 Hotline at 956-394-0012 or visit the Brownsville Cares website for more information regarding COVID-19 vaccines.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

Texas Adds New Condition to Mandatory Newborn Screening Tests

The Texas Department of State Health Services added a new enzyme deficiency test on June 1, 2026, to its newborn screening panel, meaning that all Texas newborns are now tested for 60 rare, genetic conditions. Tests for hearing loss and critical congenital heart disease are additional point-of-service tests typically conducted by the birthing center. 

Pancreatic Cancer Patients Gain Early Access to Experimental Drug Daraxonrasib Following Fast-Track FDA Decision

The U.S. Food and Drug Administration is announcing that it issued a “safe to proceed” letter to Revolution Medicines, allowing the sponsor to initiate an expanded access treatment protocol (EAP) for its experimental pancreatic cancer drug, daraxonrasib.

STHS GME Consortium Encourages Community to “Walk with a Doc”, June 6th

Mega Doctor News In an era defined by high-intensity workouts, wearable fitness trackers and advanced training techniques, one of simplest...

STHS Children’s Marks 20th Anniversary with Gala Honoring Pediatric Providers Behind Its Success

For the past 20 years, South Texas Health System Children’s has stood as a place where compassionate care and clinical excellence come together to create hope for children and their families.
- Advertisement -